Early data on valve-in-valve procedures for failing aortic bioprostheses indicate that the procedure is clinically effective in the majority of patients, although safety and efficacy concerns persist.

For patients with failing bioprosthetic surgical mitral valves, the transcatheter mitral valve-in-valve (ViV) procedure provides early outcomes similar to those seen with repeat surgical replacement, ...